InvestorsHub Logo
Followers 33
Posts 2837
Boards Moderated 2
Alias Born 10/24/2015

Re: jondoeuk post# 14

Monday, 05/02/2022 5:06:30 PM

Monday, May 02, 2022 5:06:30 PM

Post# of 265
852: Discovery of a Novel C07:02-Resticted Epitope on MAGE-A1 and Pre-Clinical Development of an Enhanced TCR-T Cell Therapy Candidate for the Treatment of Solid Tumors https://annualmeeting.asgct.org/abstracts/abstract-details?abstractId=1772

1095: Multiplexed TCR-T Cell Therapy: A Strategy to Enhance the Efficacy of Engineered T Cell Therapy https://annualmeeting.asgct.org/abstracts/abstract-details?abstractId=1995

317: Discovery of TSC-200-A02: A Natural HPV16 E7-Specific TCR-T Cell Therapy Candidate for the Treatment of HPV-Positive Solid Tumors https://annualmeeting.asgct.org/abstracts/abstract-details?abstractId=1271
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TCRX News